Surge in Kratom Poison Center Calls Demands Heightened Compliance from Merchants

Surge in Kratom Poison Center Calls Demands Heightened Compliance from Merchants

Los Angeles, CA – A recent report by the Los Angeles Times highlights a concerning trend: kratom-related calls to U.S. poison centers have surged by an alarming 1,200% over the past decade. This dramatic increase, detailed in a study utilizing data from the National Poison Data System, underscores an urgent need for enhanced product safety and rigorous compliance within the kratom industry.

What Happened: A Decade of Rising Concerns

Between 2015 and 2025, U.S. poison control centers fielded 14,449 calls related to kratom exposure. A significant portion of these, 3,434 calls, occurred in 2025 alone, marking a substantial jump from just 258 calls in 2015. The study, led in part by UVA Health researchers, also revealed a corresponding rise in hospitalizations. While 62% of calls involved kratom used by itself, 38% involved co-ingestion with other substances, most frequently alcohol, opioids, benzodiazepines, cannabis, stimulants, and antidepressants. The report also noted 233 deaths linked to kratom during the study period, with 184 of these involving multiple substances. Researchers attribute this rise to both the increased availability of kratom products and the growing potency of newer formulations.

Why This Matters to Kratom Merchants and Consumers

This news carries significant weight for both kratom merchants and consumers. For consumers, the data raises critical questions about product safety, consistency, and the potential risks associated with kratom, especially when combined with other substances. For merchants, this surge in adverse event reports signals increased scrutiny from regulatory bodies and the public. It could fuel calls for stricter federal and state regulations, potentially impacting market access and operational costs. The industry's reputation is also at stake; maintaining consumer trust will depend heavily on demonstrating a commitment to safety and transparency.

Compliance Implications for the Kratom Industry

The escalating number of poison center calls reinforces the necessity of robust regulatory frameworks like the Kratom Consumer Protection Act (KCPA). Where adopted at the state level, the KCPA typically mandates age restrictions, clear labeling standards, and crucial lab testing requirements to prevent contamination and adulteration. States like North Carolina and South Carolina have already implemented comprehensive testing frameworks, requiring products to undergo ISO/IEC 17025-accredited laboratory testing. These laws set specific thresholds for alkaloid content (e.g., mitragynine between 0.5% and 2%, 7-hydroxymitragynine not exceeding 0.02%) and require screening for heavy metals and microbial contaminants. This trend suggests a broader shift towards standardization that other states may follow.

What High-Risk Merchants Need to Know: COAs, Lab Testing, and Regulatory Compliance

For high-risk kratom merchants, proactive and stringent adherence to quality control and regulatory compliance is no longer optional—it's imperative.

1. Third-Party Lab Testing: Every batch of kratom product must undergo comprehensive third-party lab testing. This ensures unbiased and accurate results regarding purity, potency, and safety.
2. Robust Certificates of Analysis (COAs): A complete COA is your primary tool for demonstrating product integrity. It should include:
   • Batch/Lot Identification Number: This must precisely match the product for traceability.
   • Dates: Clearly state the date the sample was received and the date testing was completed.
   • Methods of Analysis: Detail the scientific methods used for each test.
   • Alkaloid Profile: Accurately report the levels of mitragynine and 7-hydroxymitragynine, ensuring they fall within safe and compliant ranges.
   • Contaminant Screening: Verify that products are free from harmful levels of heavy metals (lead, arsenic, cadmium, mercury), microbes (e.g., salmonella, E. coli), and pesticides.
   • Lab Credentials: Ensure testing is performed by an ISO/IEC 17025-accredited laboratory, signifying adherence to international quality standards.
3. Transparency and Accessibility: Make COAs readily available to consumers, either on your website, via QR codes on packaging, or upon request. This builds trust and demonstrates a commitment to consumer safety.
4. Good Manufacturing Practices (GMP): Adhering to GMP standards ensures that products are consistently produced and controlled according to quality standards, covering everything from raw material handling to packaging.
5. Accurate Labeling: Labels must clearly state ingredients, serving sizes, warnings, and the exact mitragynine and 7-hydroxymitragynine content. Avoid making unsubstantiated medical claims.

The rise in kratom-related poison center calls is a stark reminder of the responsibilities held by every participant in the kratom supply chain. By embracing stringent compliance, comprehensive lab testing, and transparent practices, the industry can work towards a safer future for consumers and mitigate the risk of further regulatory intervention.